Torrent Pharmaceuticals Limited — Others, 20-05-2025: Appointment

Torrent Pharmaceuticals has announced a board meeting to approve the financial results for the quarter and half-year. Consolidated revenue rose 8% YoY to Rs. 2,959 Cr in Q4 FY25, with net profit up 11% to Rs. 498 Cr. The India business grew 12%, led by chronic therapies, while Brazil’s reported revenue declined 6% due to currency effects but grew 5% on a constant currency basis. Germany and the US markets showed steady growth. Aman Mehta will join as Managing Director from August 1, 2025, to drive growth and strategy.